Mali Barbi

887 total citations
13 papers, 126 citations indexed

About

Mali Barbi is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Mali Barbi has authored 13 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Mali Barbi's work include interferon and immune responses (2 papers), RNA regulation and disease (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Mali Barbi is often cited by papers focused on interferon and immune responses (2 papers), RNA regulation and disease (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Mali Barbi collaborates with scholars based in United States, Israel and Italy. Mali Barbi's co-authors include Orna Elroy‐Stein, Irit Gat‐Viks, John Kang, Mohamed Gabr, Kristin A. Swedish, Tamar Geiger, V. Prímache, S. Binda, Giuseppe De Benedittis and David Chetrit and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Mali Barbi

11 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mali Barbi United States 6 46 33 23 23 19 13 126
Julia Adam United Kingdom 5 32 0.7× 59 1.8× 14 0.6× 9 0.4× 50 2.6× 5 279
Yuanjun Qin China 6 32 0.7× 17 0.5× 94 4.1× 48 2.1× 9 0.5× 13 299
A Șerban Italy 10 24 0.5× 62 1.9× 41 1.8× 24 1.0× 19 1.0× 27 216
Huijia Qiu China 7 41 0.9× 43 1.3× 47 2.0× 4 0.2× 14 0.7× 9 174
Abdul Latif Bangladesh 7 58 1.3× 92 2.8× 13 0.6× 4 0.2× 33 1.7× 17 244
Ronghuan Yu China 6 58 1.3× 12 0.4× 11 0.5× 7 0.3× 14 0.7× 8 152
Ruilin Wu Canada 6 33 0.7× 17 0.5× 26 1.1× 32 1.4× 7 0.4× 14 121
Elena Díaz‐García Spain 8 69 1.5× 10 0.3× 34 1.5× 43 1.9× 16 0.8× 21 184
Kyomin Choi South Korea 7 23 0.5× 14 0.4× 39 1.7× 9 0.4× 9 0.5× 22 109
Mariola Bednorz Germany 6 61 1.3× 16 0.5× 5 0.2× 13 0.6× 25 1.3× 8 195

Countries citing papers authored by Mali Barbi

Since Specialization
Citations

This map shows the geographic impact of Mali Barbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mali Barbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mali Barbi more than expected).

Fields of papers citing papers by Mali Barbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mali Barbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mali Barbi. The network helps show where Mali Barbi may publish in the future.

Co-authorship network of co-authors of Mali Barbi

This figure shows the co-authorship network connecting the top 25 collaborators of Mali Barbi. A scholar is included among the top collaborators of Mali Barbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mali Barbi. Mali Barbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Barbi, Mali, et al.. (2024). Real-world comparison: Neoadjuvant pembrolizumab (pembro-NACT) vs. dose-dense neoadjuvant chemotherapy (ddNACT) in early stage triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 42(16_suppl). e12615–e12615. 1 indexed citations
3.
Barbi, Mali, et al.. (2024). Generation and Maintenance of Patient-Derived Endometrial Cancer Organoids. BIO-PROTOCOL. 14(1355). e5093–e5093.
4.
Barbi, Mali, et al.. (2024). Navigating Hormone Therapy in Postmenopausal Women: Balancing Symptom Relief With Cancer Risk. Journal of Clinical Oncology. 42(30). 3517–3522. 1 indexed citations
5.
Barbi, Mali, Richard D. Carvajal, & Craig Devoe. (2024). Updates in the Management of Uveal Melanoma. The Cancer Journal. 30(2). 92–101. 3 indexed citations
6.
Asad, Mohammad, et al.. (2021). Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease. Frontiers in Immunology. 12. 695815–695815. 10 indexed citations
7.
Kang, John, et al.. (2021). Rhabdomyolysis in COVID-19 Patients: A Retrospective Observational Study. Cureus. 13(1). e12552–e12552. 42 indexed citations
8.
Barbi, Mali, Valerie Fong, Mohammad Asad, et al.. (2021). Risk Factors Associated With COVID-19 Related Anosmia And Ageusia. Journal of Allergy and Clinical Immunology. 147(2). AB134–AB134. 1 indexed citations
9.
Barbi, Mali, Della Makower, & Joseph A. Sparano. (2021). The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes. Therapeutic Advances in Medical Oncology. 13. 4277450499–4277450499. 7 indexed citations
10.
Asad, Mohammad, Valerie Fong, Meaghan O’Neill, et al.. (2021). Loss of sense of smells associated with sour taste is a possible diagnostic marker for COVID-19. Journal of Allergy and Clinical Immunology. 147(2). AB163–AB163. 1 indexed citations
11.
Gat‐Viks, Irit, et al.. (2015). Proteomics‐level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease. Journal of Neurochemistry. 134(3). 513–526. 24 indexed citations
12.
Barbi, Mali, et al.. (2012). Poor Cerebral Inflammatory Response in eIF2B Knock-In Mice: Implications for the Aetiology of Vanishing White Matter Disease. PLoS ONE. 7(10). e46715–e46715. 21 indexed citations
13.
Prímache, V., S. Binda, Giuseppe De Benedittis, & Mali Barbi. (1998). In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus.. PubMed. 21(4). 397–401. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026